158 related articles for article (PubMed ID: 15193893)
1. Prostate-specific antigen test use reported in the 2000 National Health Interview Survey.
Ross LE; Coates RJ; Breen N; Uhler RJ; Potosky AL; Blackman D
Prev Med; 2004 Jun; 38(6):732-44. PubMed ID: 15193893
[TBL] [Abstract][Full Text] [Related]
2. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey.
Swan J; Breen N; Coates RJ; Rimer BK; Lee NC
Cancer; 2003 Mar; 97(6):1528-40. PubMed ID: 12627518
[TBL] [Abstract][Full Text] [Related]
3. Behavioral associations between prostate and colon cancer screening.
Carlos RC; Underwood W; Fendrick AM; Bernstein SJ
J Am Coll Surg; 2005 Feb; 200(2):216-23. PubMed ID: 15664097
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with men's use of prostate-specific antigen screening: evidence from Health Information National Trends Survey.
Finney Rutten LJ; Meissner HI; Breen N; Vernon SW; Rimer BK
Prev Med; 2005 Apr; 40(4):461-8. PubMed ID: 15530599
[TBL] [Abstract][Full Text] [Related]
5. Decision making in prostate-specific antigen screening National Health Interview Survey, 2000.
Han PK; Coates RJ; Uhler RJ; Breen N
Am J Prev Med; 2006 May; 30(5):394-404. PubMed ID: 16627127
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen levels in the United States: implications of various definitions for abnormal.
Welch HG; Schwartz LM; Woloshin S
J Natl Cancer Inst; 2005 Aug; 97(15):1132-7. PubMed ID: 16077071
[TBL] [Abstract][Full Text] [Related]
7. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
Culp S; Porter M
BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
[TBL] [Abstract][Full Text] [Related]
8. Demographics and health-related factors of men receiving prostate-specific antigen screening in Utah.
Merrill RM
Prev Med; 2001 Dec; 33(6):646-52. PubMed ID: 11716662
[TBL] [Abstract][Full Text] [Related]
9. Screening for prostate cancer in U.S. men ACPM position statement on preventive practice.
Lim LS; Sherin K;
Am J Prev Med; 2008 Feb; 34(2):164-70. PubMed ID: 18201648
[TBL] [Abstract][Full Text] [Related]
10. Self-reported prostate cancer screening in Austria.
Vutuc C; Waldhoer T; Sevelda P; Micksche M; Haidinger G
J Med Screen; 2006; 13(3):148-51. PubMed ID: 17007656
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).
Hoffman RM; Couper MP; Zikmund-Fisher BJ; Levin CA; McNaughton-Collins M; Helitzer DL; VanHoewyk J; Barry MJ
Arch Intern Med; 2009 Sep; 169(17):1611-8. PubMed ID: 19786681
[TBL] [Abstract][Full Text] [Related]
12. The distribution of serum prostate-specific antigen levels among American men: implications for prostate cancer prevalence and screening.
Porter MP; Stanford JL; Lange PH
Prostate; 2006 Jul; 66(10):1044-51. PubMed ID: 16598738
[TBL] [Abstract][Full Text] [Related]
13. Total and percent free prostate-specific antigen levels among U.S. men, 2001-2002.
Saraiya M; Kottiri BJ; Leadbetter S; Blackman D; Thompson T; McKenna MT; Stallings FL
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2178-82. PubMed ID: 16172229
[TBL] [Abstract][Full Text] [Related]
14. Promoting prostate-specific antigen informed decision-making. Evaluating two community-level interventions.
Driscoll DL; Rupert DJ; Golin CE; McCormack LA; Sheridan SL; Welch BM; Poehlman JA
Am J Prev Med; 2008 Aug; 35(2):87-94. PubMed ID: 18617077
[TBL] [Abstract][Full Text] [Related]
15. Age-specific patterns of prostate-specific antigen testing among primary care physician visits.
McNaughton Collins M; Stafford RS; Barry MJ
J Fam Pract; 2000 Feb; 49(2):169-72. PubMed ID: 10718695
[TBL] [Abstract][Full Text] [Related]
16. Trends in prostate-specific antigen testing from 1995 through 2004.
Farwell WR; Linder JA; Jha AK
Arch Intern Med; 2007 Dec; 167(22):2497-502. PubMed ID: 18071173
[TBL] [Abstract][Full Text] [Related]
17. Predictors of prostate cancer screening among health fair participants.
Chiu BC; Anderson JR; Corbin D
Public Health; 2005 Aug; 119(8):686-93. PubMed ID: 15949522
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer screening trends of New York State men at least 50 years of age, 1994 to 1997.
McDavid K; Melnik TA; Derderian H
Prev Med; 2000 Sep; 31(3):195-202. PubMed ID: 10964632
[TBL] [Abstract][Full Text] [Related]
19. Cancer screening among Latino subgroups in the United States.
Gorin SS; Heck JE
Prev Med; 2005 May; 40(5):515-26. PubMed ID: 15749133
[TBL] [Abstract][Full Text] [Related]
20. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
